| __timestamp | Dynavax Technologies Corporation | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 11032000 | 28336824 |
| Thursday, January 1, 2015 | 4050000 | 32319194 |
| Friday, January 1, 2016 | 11043000 | 29404631 |
| Sunday, January 1, 2017 | 327000 | 31769230 |
| Monday, January 1, 2018 | 8198000 | 20439380 |
| Tuesday, January 1, 2019 | 35219000 | 24186536 |
| Wednesday, January 1, 2020 | 46551000 | 4680000 |
| Friday, January 1, 2021 | 439442000 | 4898000 |
| Saturday, January 1, 2022 | 722683000 | 155984000 |
| Sunday, January 1, 2023 | 232284000 | 496659000 |
Unleashing the power of data
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and potential. Over the past decade, Telix Pharmaceuticals Limited and Dynavax Technologies Corporation have showcased contrasting revenue trajectories.
From 2014 to 2023, Dynavax experienced a dramatic revenue surge, peaking in 2022 with a staggering 6,450% increase from its 2017 low. This growth was primarily driven by strategic product launches and market expansions.
Telix, on the other hand, demonstrated a more consistent growth pattern. Despite a dip in 2020, the company rebounded impressively, achieving a 1,650% increase in revenue by 2023 compared to its 2014 figures. This steady climb reflects Telix's robust pipeline and strategic partnerships.
Both companies exemplify the diverse paths to success in the biotech sector, offering valuable insights for investors and industry enthusiasts alike.
Novo Nordisk A/S vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Amgen Inc. and Dynavax Technologies Corporation: A Comprehensive Revenue Analysis
Revenue Showdown: Sanofi vs Telix Pharmaceuticals Limited
Revenue Insights: Gilead Sciences, Inc. and Dynavax Technologies Corporation Performance Compared
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Telix Pharmaceuticals Limited
Who Generates More Revenue? Alnylam Pharmaceuticals, Inc. or Dynavax Technologies Corporation
Biogen Inc. or Telix Pharmaceuticals Limited: Who Leads in Yearly Revenue?
Revenue Showdown: United Therapeutics Corporation vs Dynavax Technologies Corporation
Breaking Down Revenue Trends: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Breaking Down Revenue Trends: Merus N.V. vs Dynavax Technologies Corporation
Comparing Revenue Performance: Ligand Pharmaceuticals Incorporated or Dynavax Technologies Corporation?
Revenue Insights: Dynavax Technologies Corporation and Galapagos NV Performance Compared